Pediatric Primary Cutaneous Marginal Zone Lymphoma Treated With Doxycycline.
1Children's Hospital Los Angeles, California. Dr. Chan is from the Pediatric Residency Program. Dr. Kamath is from the Pediatric Dermatology Department. Dr. Kamath also is from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.
Cutis
|December 13, 2023
Summary
Primary cutaneous marginal zone lymphoma (PCMZL) is rare in children. A 13-year-old boy with PCMZL showed lesion improvement with doxycycline and intralesional triamcinolone, supporting doxycycline use for pediatric cases.
Area of Science:
- Dermatology
- Pediatric Oncology
- Hematology
Background:
- Primary cutaneous marginal zone lymphoma (PCMZL) is a rare B-cell lymphoma affecting the skin.
- Pediatric cases of PCMZL are exceptionally uncommon, presenting unique diagnostic and therapeutic challenges.


